PMID: 3758148Jan 1, 1986Paper

Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease

European Journal of Clinical Pharmacology
M Láznícek, K E Senius

Abstract

The protein binding of tolfenamic acid in plasma from patients with renal and hepatic disorders was studied by equilibrium dialysis. Drug binding to the cellular components of whole blood and blood cell suspensions was also measured. Salicylic acid was used as the reference drug in all experiments. Renal and hepatic diseases increased the unbound fraction of tolfenamic acid. Free drug fractions were significantly correlated with changes in creatinine, urea, and total bilirubin, but not with those in albumin or total protein in plasma. Comparison of the theoretical binding parameters in control plasma and similar changes in protein binding in all the plasma samples studied revealed that tolfenamic acid and salicylic acid probably share a common primary binding site. The significance of the correlation permits use of salicylic acid as a model drug for predicting changes in the protein binding of tolfenamic acid. The measurements of binding properties in whole blood and blood cell--buffer suspension showed that tolfenamic acid interacts with the lipid membrane structures of blood cells, while salicylic acid is distributed into the aqueous cell space.

References

Aug 18, 1979·Lancet·H HakkarainenJ Parantainen
Oct 1, 1979·Prostaglandins·A KauppilaO Ylikorkala
Jan 1, 1976·Scandinavian Journal of Rheumatology·I B LindénH Vapaatalo
Oct 1, 1976·Clinical Pharmacology and Therapeutics·O BorgåA Norlin
Jan 1, 1976·Scandinavian Journal of Rheumatology·A KajanderG Gothoni
Apr 4, 1975·European Journal of Clinical Pharmacology·M Affrime, M M Reidenberg
Jan 1, 1974·The Journal of Pharmacy and Pharmacology·S AgurellU Lönroth
Sep 1, 1974·Clinical Pharmacology and Therapeutics·M EhrneboU Lönroth
Jan 1, 1972·Scandinavian Journal of Rheumatology·A KajanderG Gothoni
Sep 1, 1974·The Medical Clinics of North America·M M Reidenberg
Jan 1, 1973·Acta Pharmacologica Et Toxicologica·F Andreasen
May 1, 1980·Clinical Pharmacokinetics·K M Piafsky
Jan 1, 1980·Annual Review of Pharmacology and Toxicology·R L Williams, L Z Benet
Apr 1, 1981·Biochemical Pharmacology·K J FehskeU Wollert
Jan 1, 1982·Clinical Pharmacokinetics·S WanwimolrukP M Brooks
Oct 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·P J PentikäinenC E Hignite
Oct 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·R G KhalifahP J Neuvonen
Nov 15, 1982·Biochemical Pharmacology·S UrienJ P Tillement
Jan 1, 1981·European Journal of Clinical Pharmacology·P J PentikäinenC Backman
May 1, 1980·Clinical Pharmacology and Therapeutics·S ErillR Carlos

❮ Previous
Next ❯

Citations

Jan 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·M Láznícek, A Láznícková
May 9, 2002·European Journal of Drug Metabolism and Pharmacokinetics·Alice LaznickovaAkira Yokoyama
Jan 1, 1989·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·A LázníckováJ Kvĕtina
Mar 12, 2004·Nuclear Medicine and Biology·Martin KopeckyHelmut R Mäcke
Dec 10, 2002·Cancer Biotherapy & Radiopharmaceuticals·M LaznicekS Wenger
Jul 1, 1990·The Journal of Pharmacy and Pharmacology·M LáznícekJ Kvĕtina
Mar 1, 1992·The Journal of Pharmacy and Pharmacology·M Láznícek
Oct 21, 1999·The Journal of Pharmacy and Pharmacology·M Laznicek, A Laznickova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved